TMEM158 and ovarian carcinoma: In recent years, TMEM158 upregulation was reported in multiple human cancers, including colon cancers (6), thyroid cancers (7, 8), triple-negative breast cancers (9), pancreatic cancers (10), laryngeal cancer (11), ovarian cancers (12), and glioblastomas (13).